Johnson & Johnson (BKK:JNJ03)

Market Cap	15.51T
Revenue (ttm)	2.97T
Net Income (ttm)	808.96B
Shares Out	n/a
EPS (ttm)	333.25
PE Ratio	19.18
Forward PE	18.00
Dividend	0.02 (0.52%)
Ex-Dividend Date	Nov 25, 2025

Volume	13,750
Average Volume	120,886
Open	3.280
Previous Close	3.280
Day's Range	3.280 - 3.300
52-Week Range	2.980 - 3.380
Beta	n/a
RSI	58.85
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: JNJ03

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD